Advanz Takes Aim At Rival's Bowel Disease Drug Patent
Pharmaceutical company Advanz has asked a London court to revoke a rival's patent in the U.K. for a bowel disease drug, arguing that the treatment is not inventive enough to deserve...To view the full article, register now.
Already a subscriber? Click here to view full article